Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Genetic Disorder
Recent news which mentions Genetic Disorder
Quoin Outlicenses Lead Asset For Skin Disorder In Middle East, North Africa
November 11, 2021
Tickers
QNRX
Tags
Contracts
News
Market News
From
Benzinga
Quoin, AFT Pharmaceuticals Ink Licensing Pact For Lead Candidate In Genetic Skin Disease
November 08, 2021
Tickers
QNRX
Tags
Biotech
QNRX
Health Care
From
Benzinga
Jennifer Doudna Spinout Mammoth Inks $700M CRISPR Deal With Vertex
October 26, 2021
Tickers
VRTX
Tags
Benzinga
Genetic Disorder
Briefs
From
Benzinga
Stealth Bio Stock Falls On FDA Refusal to File Letter For Barth Syndrome Candidate
October 20, 2021
Tickers
MITO
Tags
MITO
Genetic Disorder
Short Ideas
From
Benzinga
PTC Therapeutics' Rare Genetic Disease Gene Therapy Shows Durable Improvement Even At 5 Years
September 29, 2021
Tickers
PTCT
Tags
Benzinga
General
Genetic Disorder
From
Benzinga
Eli Lilly Inks Another RNA Collab, This Time With ProQR
September 09, 2021
Tickers
LLY
PRQR
Tags
Small Cap
Genetic Disorder
Benzinga
From
Benzinga
AstraZeneca's Drug Shows Promise In Copper Build-Up Genetic Disease
August 26, 2021
Tickers
AZN
AZNCF
Tags
AZN
General
Benzinga
From
Benzinga
Stealth Bio Files US Application For Ultra Rare Genetic Disease Candidate
August 24, 2021
Tickers
MITO
Tags
News
MITO
Market News
From
Benzinga
PTC Therapeutics' Waylivra Scores Approval In Brazil For Genetic Disorder
August 24, 2021
Tickers
IONS
PTCT
Tags
News
Market News
General
From
Benzinga
Cyclo Therapeutics' Trappsol Shows Early Safety, Efficacy In Genetic Disorder
July 30, 2021
Tickers
CYTH
Tags
Market News
News
Benzinga
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.